EUVIMEDEUVIMED entdecken
Crossref

A multi-functional nano-system combining PI3K-110α/β inhibitor overcomes P-glycoprotein mediated MDR and improves anti-cancer efficiency

Ruikun Lin, Lei Zhang, Biwei Ye, Yanan Wang, Yi-Dong Li, Hsu Jason, Wenzhen Liu, Ping Hu, Jincan Chen, Zhe-Sheng Chen, Zhuo Chen

Cancer Letters · 2023

DOI: 10.1016/j.canlet.2023.216181 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2023. Verfasst von Ruikun Lin und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian, 3…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 97 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

P-glycoprotein (P-gp/ABCB1)-mediated multidrug resistance (MDR) in cancers severely limit chemotherapeutic efficacy. We recently reported that phosphatidylinositol-3-kinase (PI3K) 110α and 110β subunits can be novel targets for reversal of P-gp mediated MDR in cancers, and BAY-1082439 as an inhibitor specific for PI3K 110α and 110β subunits could reverse P-gp-mediated MDR by downregulating P-gp expression in cancer cells. However, BAY-1082439 has very low solubility, short half-life and high in-vivo clearance rate. Till now, nano-system with the functions to target PI3K P110α and P110β and reverse P-gp mediated MDR in cancers has not been reported. In our study, a tumor targeting drug delivery nano-system PBDF was established, which comprised doxorubicin (DOX) and BAY-1082439 respectively encapsulated by biodegradable PLGA-SH nanoparticles (NPs) that were grafted to gold nanorods (Au NRs) modified with FA-PEG-SH, to enhance the efficacy to reverse P-gp mediated MDR and to target tumor cells, further, to enhance the efficiency to inhibit MDR tumors overexpressing P-gp. In-vitro experiments indicated that PBDF NPs greatly enhanced uptake of DOX, improved the activity to reverse MDR, inhibited the cell proliferation, and induced S-phase arrest and apoptosis in KB-C2 cells, as compared with free DOX combining free BAY-1082439. In-vivo experiments further demonstrated that PBDF NPs improved the anti-tumor ability of DOX and inhibited development of KB-C2 tumors. Notably, the metastasis of KB-C2 cells in livers and lungs of nude mice were inhibited by treatment with PBDF NPs, which showed no obvious in-vitro or in-vivo toxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsNeoplasmsAnimalsMiceATP Binding Cassette Transporter, Subfamily BATP Binding Cassette Transporter, Subfamily B, Member 1Cell Line, TumorDoxorubicinDrug Resistance, MultipleDrug Resistance, NeoplasmMice, NudePhosphatidylinositol 3-KinasesHumans

Stichwörter der Autor:innen

Multi-drug resistance (MDR) in cancerMultifunctional nano-systemP-glycoprotein (P-gp/ABCB1)Phosphatidylinositol-3-kinase (PI3K) 110 subunitsTumor targeting

Substanzen

Antineoplastic AgentsATP Binding Cassette Transporter, Subfamily BATP Binding Cassette Transporter, Subfamily B, Member 1DoxorubicinPhosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian, 350002, China; Fujian Agriculture and Forestry University, Fuzhou, Fuji…
  • State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian, 350002, China; University of Chinese Academy of Sciences, Fuzhou, Fujia…
  • College of Pharmacy and Health Sciences, St. John's University, Queens, New York, 11439, USA.
  • State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian, 350002, China.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Fujian Province

Zitieren

APA

Lin, R., Zhang, L., Ye, B., Wang, Y., Li, Y. D., Jason, H., Liu, W., Hu, P., Chen, J., Chen, Z. S., & Chen, Z. (2023). A multi-functional nano-system combining PI3K-110α/β inhibitor overcomes P-glycoprotein mediated MDR and improves anti-cancer efficiency. Cancer Letters. https://doi.org/10.1016/j.canlet.2023.216181

Vancouver

Lin R, Zhang L, Ye B, Wang Y, Li YD, Jason H, et al. A multi-functional nano-system combining PI3K-110α/β inhibitor overcomes P-glycoprotein mediated MDR and improves anti-cancer efficiency. Cancer Letters. 2023. doi:10.1016/j.canlet.2023.216181

BibTeX
@article{Lin2023,
  author = {Lin, Ruikun and Zhang, Lei and Ye, Biwei and Wang, Yanan and Li, Yi-Dong and Jason, Hsu and Liu, Wenzhen and Hu, Ping and Chen, Jincan and Chen, Zhe-Sheng and Chen, Zhuo},
  title = {A multi-functional nano-system combining PI3K-110α/β inhibitor overcomes P-glycoprotein mediated MDR and improves anti-cancer efficiency},
  journal = {Cancer Letters},
  year = {2023},
  doi = {10.1016/j.canlet.2023.216181}
}
Kostenlos starten →